TaiMed Biologics (ROCO:4147) COGS-to-Revenue : 0.62 (As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is TaiMed Biologics COGS-to-Revenue?

TaiMed Biologics's Cost of Goods Sold for the three months ended in Mar. 2024 was NT$110.8 Mil. Its Revenue for the three months ended in Mar. 2024 was NT$178.9 Mil.

TaiMed Biologics's COGS to Revenue for the three months ended in Mar. 2024 was 0.62.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. TaiMed Biologics's Gross Margin % for the three months ended in Mar. 2024 was 38.11%.

TaiMed Biologics COGS-to-Revenue Historical Data

The historical data trend for TaiMed Biologics's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TaiMed Biologics COGS-to-Revenue Chart

TaiMed Biologics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.67

0.56

0.80

0.62

0.54

TaiMed Biologics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial															0.37	0.67	0.51	0.56	0.62

TaiMed Biologics COGS-to-Revenue Calculation

TaiMed Biologics's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	266.544	/	491.777
	=	0.54

TaiMed Biologics's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	110.751	/	178.948
	=	0.62

TaiMed Biologics (ROCO:4147) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

TaiMed Biologics's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	110.751 / 178.948
	=	38.11 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

TaiMed Biologics COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of TaiMed Biologics's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

TaiMed Biologics (ROCO:4147) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TaiMed Biologics Inc (ROCO:4147) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 607, Ruiguang Road, 3rd Floor, Neihu District, Taipei, TWN, 11492

Website

http://www.taimedbiologics.com

TaiMed Biologics Inc is a Taiwan-based biotechnology company. It is engaged in the discovery, development, and delivery of medicines for infectious disease. It capitalizes on its intellectual, extensive expertise, and management resources to develop a health-care product pipeline that benefits patients, rewards investors, and propels to prominence in the biotechnology industry. The company's products pipeline includes TMB-365, VRC07-523LS, and others.

TaiMed Biologics (ROCO:4147) Headlines

No Headlines